Treatment of Major Depressive Disorder and Dysthymic Disorder With Antidepressants in Patients With Comorbid Opiate Use Disorders Enrolled in Methadone Maintenance Therapy
Authors:
- Paola PedrelliPPPaola Pedrelli
- Nadia IovienoNINadia Iovieno
- Mario VitaliMVMario Vitali
- Enrico TedeschiniETEnrico Tedeschini
- Kate H. BentleyKBKate H. Bentley
- George I. PapakostasGPGeorge I. Papakostas
- 1 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 31 (5) , 582-586
Abstract
Depression and opiate-use disorders (abuse, dependence) often co-occur, each condition complicating the course and outcome of the other. It has been recommended that clinicians prescribe antidepressant therapy for mood symptoms in patients with active substance-use disorders, but whether antidepressants are effective in this specific population is not entirely clear. Therefore, the aim of this study was to examine the efficacy of antidepressants in patients with unipolar major depressive disorder (MDD) and/or dysthymic disorder (DD) with comorbid opiate-use disorders currently in methadone maintenance treatment (MMT). Medline/PubMed publication databases were searched for randomized, double-blind, placebo-controlled trials of antidepressants used as monotherapy for the treatment of MDD/DD in patients with comorbid opiate-use disorders currently in MMT. The search was limited to articles published between January 1, 1980, and June 30, 2010 (inclusive). Four manuscripts were found eligible for inclusion in our analysis (n = 317 patients). We found no statistically significant difference in response rates between antidepressant and placebo therapy in trials of MDD/DD patients with comorbid opiate-use disorders currently in MMT (risk ratio for response, 1.182; 95% CI: 0.822-1.700; P = 0.366). These results show no difference in the depressive outcome of patients with comorbid opiate-use disorders on MMT whether they are on medication or placebo. Future studies examining the effectiveness of antidepressants while controlling for several variables such as psychosocial treatment and assessing the specific classes of antidepressants are needed.Keywords
This publication has 39 references indexed in Scilit:
- Epidemiologic heterogeneity of common mood and anxiety disorders over the lifecourse in the general population: a systematic reviewBMC Psychiatry, 2009
- Can Phase III Trial Results of Antidepressant Medications Be Generalized to Clinical Practice? A STAR*D ReportAmerican Journal of Psychiatry, 2009
- Relevance of Exclusion Criteria in Antidepressant Clinical TrialsJournal of Clinical Psychopharmacology, 2007
- The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design ApproachPsychotherapy and Psychosomatics, 2003
- Managing Depression in Medical OutpatientsNew England Journal of Medicine, 2000
- Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid AbusersArchives of General Psychiatry, 1997
- Early Treatment Time Course of Depressive Symptoms in Opiate AddictsJournal of Nervous & Mental Disease, 1991
- Evidence for Altered Desipramine Disposition in Methadone-Maintained Patients Treated for Cocaine AbuseThe American Journal of Drug and Alcohol Abuse, 1990
- A 2.5-year follow-up of short-term interpersonal psychotherapy in methadone-maintained opiate addictsComprehensive Psychiatry, 1986
- Diagnosis and Symptoms of Depression in Opiate AddictsArchives of General Psychiatry, 1982